|
FY2019 |
FY2020 |
FY2021 |
FY2022 |
FY2023 |
||
|
Expense-to-revenue ratio |
% |
62.3 |
67.4 |
71.5 |
67.3 |
61.9 |
|
Return on Equity (Fully Diluted) |
% |
5.1 |
4.9 |
2.2 |
4.5 |
6.0 |
|
Return on Assets |
% |
0.5 |
0.4 |
0.2 |
0.4 |
0.4 |
|
Ratio of nonperforming claims classified under the Financial Revitalization Law to total claims (Non-consolidated) |
% |
0.34 |
0.64 |
0.66 |
0.28 |
0.27 |
|
Consolidated capital ratio (Basel III, Domestic Standard) |
% |
11.21 |
11.39 |
11.72 |
10.24 |
9.92 |
|
Common Equity Tier1 Ratio (International Standard; Fully Loaded Basis) |
% |
11.28 |
11.34 |
11.58 |
10.04 |
9.80 |
Note: Due to the change in segmentation, previous periods' figures have been adjusted to conform to the current period presentation.
For more details, please browse the followings.
